- Home/
- Article /
- Overview of Clinical Trial Program and Applicability of Insulin Degludec/Insulin Aspart in Diabetes Management.
Full Author : ['Bantwal, Ganapathi', 'Wangnoo, Subhash K', 'Shunmugavelu, M', 'Nallaperumal, S', 'Harsha, K P', 'Bhattacharyya, Arpandev']
Journal Title : The Journal of the Association of Physicians of India
Chapter : Section3
Journal Year : 2015
Cited by : Not Available
Insulin degludec/insulin aspart (IDegAsp) is the first soluble coformulation combining a long-acting insulin degludec (IDeg) and rapid-acting insulin aspart (IAsp). In patients with uncontrolled type 2 diabetes (T2DM) previously treated with insulins, IDe.....
Keywords : ["insulin degludecinsulin aspart", "clinical trial program", "diabetes management", "overview", "applicability"]